Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Tatva Chintan Pharma Chem Pretax Margin % Related Terms
Tatva Chintan Pharma Chem Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543321 vs LIN, SHW, ECL: Pretax Margin % Comparison
For the Specialty Chemicals subindustry, Tatva Chintan Pharma Chem's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tatva Chintan Pharma Chem Pretax Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Tatva Chintan Pharma Chem's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Tatva Chintan Pharma Chem's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tatva Chintan Pharma Chem (BOM:543321) has a Pretax Margin % of 12.64% as of Jun. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Tatva Chintan Pharma Chem and its competitors. This is near median its historical median of 12.40. Over the past decade, Tatva Chintan Pharma Chem's Pretax Margin % has ranged from 1.98 to 24.14. According to the industry distribution chart, Tatva Chintan Pharma Chem ranks #404 out of 1579 companies in the Chemicals industry, placing it in the top 25.6%.
Is Tatva Chintan Pharma Chem's Pretax Margin % too high?
Tatva Chintan Pharma Chem's current Pretax Margin % of 12.64% is near median its 10-year median of 12.40. Over the past 10 years, this metric has ranged from a low of 1.98 to a high of 24.14. The Chemicals industry median Pretax Margin % is 5.33. Tatva Chintan Pharma Chem's value of 12.64% is 137.1% above this industry median. Based on the distribution chart, Tatva Chintan Pharma Chem ranks #404 out of 1579 companies in the Chemicals industry, which is above the industry midpoint. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's Pretax Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Tatva Chintan Pharma Chem ranks #404 out of 1579 companies for Pretax Margin %. This puts Tatva Chintan Pharma Chem in the upper half of its industry. The industry median Pretax Margin % is 5.33. Tatva Chintan Pharma Chem's value of 12.64% is 137.1% above this benchmark. Historically, Tatva Chintan Pharma Chem's own Pretax Margin % has ranged from 1.98 to 24.14 over the past decade. While the company's 10-year median is 12.40 vs. the industry median of 5.33, Tatva Chintan Pharma Chem has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Chemicals company?
The median Pretax Margin % among Chemicals companies is 5.33, based on 1,579 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tatva Chintan Pharma Chem's current Pretax Margin % of 12.64% is 137.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Tatva Chintan Pharma Chem and its competitors. For the Chemicals industry, the median Pretax Margin % is 5.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tatva Chintan Pharma Chem's current Pretax Margin % is 12.64%, which is near median its own 10-year median of 12.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (BOM:543321) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,496.82, compared to a current price of ₹1,726.45 — trading 15.3% above its estimated fair value. The current Pretax Margin % is 12.64%, which is near median its 10-year median of 12.40 and 137.1% above the Chemicals industry median of 5.33. Tatva Chintan Pharma Chem's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (BOM:543321), the current Pretax Margin % is 12.64% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tatva Chintan Pharma Chem (BOM:543321) Overvalued in 2026?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be overvalued.
The current stock price of ₹1,726.45 is trading 15.3% above its estimated GF Value™ of ₹1,496.82.
GuruFocus considers Tatva Chintan Pharma Chem to be Modestly Overvalued.
Key valuation signals for BOM:543321:
Pretax Margin %: 12.64% (near median its 10-year median of 12.40)
GF Value™: ₹1,496.82 vs. price of ₹1,726.45 (15.3% above fair value)
Industry Position: 137.1% above the Chemicals median (#404 of 1579)
No single metric tells the full story. See the BOM:543321 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
82GF Score
Get the complete analysis for BOM:543321
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543321 has been successfully added to your 
